AZR · Azora Therapeutics, Inc. (DE) · Exempt Offerings
$4.00
+0.29 (+7.82%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$10.50M
Shares
2.63M
Volume · Nov 6
78.19K
Avg daily vol (3M)
52.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-12-03 | New | Pharmaceuticals | $4,285,289 | $4,285,289 | 06b |
| 2025-05-14 | New | Pharmaceuticals | $4,815,379 | $4,815,379 | 06b |
| 2024-03-14 | New | Pharmaceuticals | $287,500 | $287,500 | 06b |
| 2023-10-26 | New | Pharmaceuticals | $3,998,582 | $3,998,582 | 06b |
| 2023-06-05 | New | Pharmaceuticals | $3,052,500 | $52,500 | 06b |
| 2023-03-06 | New | Pharmaceuticals | $61,603 | $61,603 | 06b |
| 2022-02-17 | New | Pharmaceuticals | $10,000,000 | $10,000,000 | 06b |
| 2021-07-12 | New | Pharmaceuticals | $5,000,000 | $500,004 | 06b |
| 2021-03-26 | New | Pharmaceuticals | $2,100,003 | $291,003 | 06b |
| 2020-11-30 | New | Pharmaceuticals | $15,295,750 | $295,750 | 06b |
| 2020-09-25 | New | Pharmaceuticals | $500,000 | $500,000 | 06b |
| 2020-06-17 | New | Pharmaceuticals | $5,217,000 | $5,217,000 | 06b |
Showing 1–12 of 12 filings